BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 635897)

  • 1. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
    Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K
    Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
    Clin Exp Hypertens (1978); 1980; 2(3-4):693-708. PubMed ID: 7000466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():247s-250s. PubMed ID: 396074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of urinary kallikrein excretion to urinary potassium excretion during furosemide administration with and without amiloride.
    Obika LF
    Arch Int Physiol Biochim; 1987 Mar; 95(1):13-8. PubMed ID: 2441670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary kallikrein in normal renin essential hypertension.
    Lawton WJ; Fitz AE
    Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between kallikrein and PRA after intravenous furosemide.
    Cinotti GA; Stirati G; Taggi F; Ronci R; Simonetti BM; Pierucci A
    J Endocrinol Invest; 1979; 2(2):147-50. PubMed ID: 489923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased urinary kallikrein excretion in young borderline hypertensive patients.
    Ando K; Fujita T
    Clin Exp Hypertens A; 1983; 5(6):903-18. PubMed ID: 6349868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary prostaglandins and kallikrein in essential hypertension.
    Weber PC; Scherer B; Held E; Siess W; Stoffel H
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():259s-261s. PubMed ID: 396075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral potassium on urinary kallikrein excretion in essential hypertension.
    Murakami E; Hiwada K; Kokubu T; Imamura Y
    Adv Exp Med Biol; 1989; 247B():133-7. PubMed ID: 2610052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A circadian variation in the excretion of urinary kinin, kallikrein and prostaglandin E in normal volunteers.
    Abe K; Sato M; Kasai Y; Haruyama T; Sato K; Miyazaki S; Imai Y; Hiwatari M; Itoh T; Sakurai Y; Goto T; Tajima J; Seino M; Yoshinaga K
    Jpn Circ J; 1981 Sep; 45(9):1098-103. PubMed ID: 7029030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and tissue kallikrein-kinin systems during acute administration of frusemide in normotensive and hypertensive humans.
    Ohman KP; Karlberg BE
    Clin Sci (Lond); 1991 Sep; 81(3):305-11. PubMed ID: 1655330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary kallikrein excretion in essential and mineralocorticoid hypertension.
    Holland OB; Chud JM; Braunstein H
    J Clin Invest; 1980 Feb; 65(2):347-56. PubMed ID: 7356684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal urinary kallikrein in normotensive and hypertensive rats during enhanced excretion of water and electrolytes.
    Croxatto HR; Albertini R; Arriagada R; Roblero J; Rojas M; Rosas R
    Clin Sci Mol Med Suppl; 1976 Dec; 3():259s-261s. PubMed ID: 1071623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationships between the renal kallikrein-kinin and prostaglandin systems in furosemide-induced diuresis.
    Ayano Y; Yamasaki K; Soejima H; Ikegami K
    Urol Int; 1984; 39(1):52-7. PubMed ID: 6587655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natriuretic responses in labile hypertension.
    Luft FC; Grim CE; Fineberg NS; Henry DP; Weinberger MH
    Am J Med Sci; 1982; 283(3):119-28. PubMed ID: 7044124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive humoral systems and sodium transport in erythrocytes of normotensive offsprings of essential hypertensive subjects.
    Janata V; Bultasová H; Pinsker P
    Physiol Bohemoslov; 1990; 39(1):65-70. PubMed ID: 2142790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary kallikrein activity is not altered in human essential hypertension.
    Simonetti BM; Pierucci A; Taggi F; Morabito S; Vastano S; Marchetti S; Putini RL; Stirati G; Cinotti GA
    Uremia Invest; 1985-1986; 9(2):189-93. PubMed ID: 3915922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats.
    Johnston CI; Matthews PG; Dax E
    Clin Sci Mol Med Suppl; 1976 Dec; 3():283s-286s. PubMed ID: 1071628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.